IGF1 and Alzheimer disease: As demonstrated by quantitative real-time polymerase chain reaction (qRT-PCR) experiment in advanced AD brains, IGF1 mRNA levels and overall expression of its receptors were apparently diminished with the increase of Braak stage [62].